Chapters

Transcript

Video

What are the challenges of optimizing therapy—even with glucocorticoids—considering that in CAH the aldosterone, androgen, and glucocorticoid pathways are coupled with one another?

What are the challenges of optimizing therapy—even with glucocorticoids—considering that in CAH the aldosterone, androgen, and glucocorticoid pathways are coupled with one another?


Created by

CMEducation Resources | iQ&A Congenital Adrenal Hyperplasia (CAH) Medical Intelligence Zone 

Presenter

Phyllis W. Speiser, MD

Phyllis W. Speiser, MD

Associate Professor, Institute of Molecular Medicine
Feinstein Institutes for Medical Research
Emerita Professor, Pediatrics Donald and Barbara Zucker School of Medicine
Hofstra/Northwell
New Hyde Park, NY